NAICS Category 325414 focuses on the manufacturing of biological products, excluding diagnostic substances. This category encompasses the production of various biologics such as vaccines, antibody-based therapies, cellular and gene therapies, and other advanced biological materials used in medical research, pharmaceutical development, and clinical applications. Manufacturers in this category develop complex biological products derived from living organisms, utilizing sophisticated cell culture, genetic engineering, and biotechnology techniques. The federal contract awards in this category demonstrate significant activity across multiple agencies, particularly the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Department of Veterans Affairs (VA). Awards typically range from $10,000 to $800,000, with contract durations spanning several months to multiple years. Frequent awardees include companies like Fujifilm Cellular Dynamics, Life Technologies Corporation, Prolacta Bioscience, and Illumina. These awards frequently support research, diagnostic development, vaccine production, and specialized biological material procurement. Most awards are not set aside, allowing full and open competition, though some opportunities are designated for small businesses. Recent federal contract opportunities in this NAICS category focus on specialized biological product development and procurement. The CDC has solicited opportunities for recombinant protein production, oligonucleotide synthesis, and viral antigen research. The NIH has posted requirements for human cell lines, hepatocyte procurement, and lentiviral vector production. The Department of Defense has sought vaccine manufacturing, including influenza and Japanese encephalitis vaccines. Performance locations are predominantly in research-intensive regions like Maryland, Wisconsin, California, and Georgia, with federal agencies seeking innovative biological solutions for medical research, public health, and military health preparedness.
Name | Description | Awardee | Potential Value (Click to sort descending) | Award Date (Click to sort descending) | Last Date To Order (Click to sort descending) | Updated At (Click to sort descending) |
|---|---|---|---|---|---|---|
HHSN263200790003B | Pelican Group Holdings Incorporated | $0 | 5/16/07 | 9/14/12 | 9/28/12 | |
75N98025A00009 | Research And Diagnostic Systems, Inc. | $100.0m | 11/1/24 | 9/30/25 | 10/28/24 | |
HHSN263201100036B | Lifesensors Inc. | $0 | 2/4/11 | 4/15/12 | 4/20/12 | |
V247P2013A | The American National Red Cross | $0 | 10/1/06 | 9/30/08 | 10/1/06 | |
HHSN263201400051B | IPM Scientific, Inc. | $0 | 8/22/14 | 7/31/24 | 7/24/24 |
Name | Description | Awardee | Potential Value (Click to sort descending) | Award Date (Click to sort descending) | Completion Date (Click to sort descending) | Updated At (Click to sort descending) |
|---|---|---|---|---|---|---|
Purchase Order 75N91021P00875 | New England Biolabs, Inc. | $15.0k | 9/4/21 | 9/19/22 | 9/4/21 | |
Purchase Order 75N93023P01190 | New England Biolabs, Inc. | $19.9k | 9/1/23 | 12/29/23 | 8/31/23 | |
Purchase Order 75N93025P00087 | New England Biolabs, Inc. | $19.9k | 11/25/24 | 6/30/25 | 12/9/24 | |
Purchase Order HHSN272201501189P | Qiagen, LLC | $14.0k | 8/26/15 | 9/5/15 | 9/26/17 | |
Purchase Order N0018322P0522 | Abbott Rapid DX North America LLC | $12.9k | 9/6/22 | 9/16/22 | 9/6/22 |
A Portfolio Platform of GovExec © 2025